IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 61 filers reported holding IMMUNE DESIGN CORP in Q1 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COLUMN GROUP L P | 3,161,942 | $65,294,000 | 100.00% |
| ProQuest Associates IV LLC | 1,983,858 | $40,967,000 | 8.41% |
| Iguana Healthcare Management, LLC | 150,000 | $3,098,000 | 0.98% |
| SECTORAL ASSET MANAGEMENT INC | 810,390 | $16,735,000 | 0.70% |
| Cormorant Asset Management, LP | 189,000 | $3,903,000 | 0.52% |
| SPHERA FUNDS MANAGEMENT LTD. | 140,000 | $2,891,000 | 0.28% |
| RS INVESTMENT MANAGEMENT CO LLC | 750,402 | $15,496,000 | 0.13% |
| Eventide Asset Management | 102,904 | $2,125,000 | 0.12% |
| Rock Springs Capital Management LP | 55,000 | $1,136,000 | 0.08% |
| Focused Wealth Management, Inc | 3,406 | $70,000 | 0.04% |